Industry Insights
Proteomics Experts Unite for EPIC-XS
Industry InsightThe European Proteomics Infrastructure Consortium providing access (EPIC-XS) consists of a network of experienced research groups that share one common goal: to facilitate the development and sustainability of proteomics explorations to researchers within the European Union. We spoke with Martina O’Flaherty from the EPIC-XS project office to learn more.
Read More
Tiny Protein Has Huge Potential in CRISPR
Industry InsightLast year the smallest CRISPR protein, Cas14 was discovered. We spoke to the scientists that made the discovery, Lucas Harrington, at Mammoth Biosciences, to learn more about Cas14.
Read More
Take a Good Book Around
Industry InsightOur recent social media poll on "book recommendations for scientists" provided an incredible response. We decided to collate this information and give you the perfect excuse to treat yourself to a new read. Enjoy!
Read More
Microfluidics Solutions to Proteomics Problems
Industry InsightMicrofluidic platforms are becoming commonplace across biological science. To find out more about how microfluidic technology is revolutionizing protein analysis, we spoke to Tuomas Knowles, Founder and Chief Scientific Officer, Fluidic Analytics.
Brain Injury Diagnosed With Single Drop of Blood: a Follow-up
Industry InsightWhat do biomarkers and a 1990s TGIF party have in common? Find out here...
TBIcheck is a rapid point-of-care diagnostic device that detects biomarkers indicative of mild traumatic brain injury. To find out more, we spoke with the head of the Biomedical Proteomics Group, Jean-Charles Sanchez.
The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
Industry InsightLiquid biopsy is a less invasive approach compared to traditional surgical biopsies. By collecting a simple blood sample and analyzing circulating tumor DNA (ctDNA), cancer researchers and healthcare professionals can access a myriad of information about a patient’s tumor.
Read More
Sustainability Through Innovation
Industry InsightWith growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Read More
Biomarkers and the Future of Precision Medicine
Industry InsightBiomarkers hold immense potential for the future of medicine, enabling more efficient and better-targeted treatments. Most coverage of novel biomarkers to date has been focused on how a patient’s genetic signature can indicate their susceptibility to a disease, but there is a world of other biological and environmental information that can impact how patients respond to treatments. In this blog, SCIEX’s Aaron Hudson explains how non-genetic biomarkers have a key role to play in reaching the goal of truly precise medicine.
Designing Proteins Bit by Bit
Industry InsightCell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.
Read More
Students Get Hands-on with Mass Spectrometry
Industry InsightWe spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.
Read More
